Ryuma Tanaka
Impact in
-
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
- Genomics and Rare Diseases
-
- CAR-T cell therapy research
Papers in
- Genetics 4
- Glioma Diagnosis and Treatment 3
- Co-authors
- Amy B. Heimberger (3 shared papers)Xiaoyang Ling (2 shared papers)Hillary G. Caruso (2 shared papers)Verlene Henry (1 shared paper)Aria Sabbagh (1 shared paper)Jiyong Liang (1 shared paper)Ibrahim Qaddoumi (3 shared papers)Naoto Hara (1 shared paper)
- Journals
- Neuro-Oncology (2 papers)Journal of Neuro-Oncology (2 papers)Molecular Case Studies (1 paper)Microporous and Mesoporous Materials (1 paper)Cancer Medicine (1 paper)
- Partner nations
- JapanUnited StatesSouth Africa
In The Last Decade
Ryuma Tanaka
18 papers receiving 139 citations
Peers
Comparison fields: 5 of 44
- Genetics 25
- Oncology 47
- Immunology 32
- Genetics 29
- Neurology 13
Countries citing papers authored by Ryuma Tanaka
This map shows the geographic impact of Ryuma Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuma Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuma Tanaka more than expected).
Fields of papers citing papers by Ryuma Tanaka
This network shows the impact of papers produced by Ryuma Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuma Tanaka. The network helps show where Ryuma Tanaka may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryuma Tanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 43 | |
| 2 | In vivo and in vitro effect of adoptive immunotherapy of experimental murine brain tumors using lymphokine-activated killer cells. | 1988 | 21 |
| 3 | 2012 | 12 | |
| 4 | 2022 | 11 | |
| 5 | 2024 | 10 | |
| 6 | 2021 | 10 | |
| 7 | 2012 | 7 | |
| 8 | 2021 | 6 | |
| 9 | 2020 | 6 | |
| 10 | Predicting outcomes of neonates born to GBS-positive women who received inadequate intrapartum antimicrobial prophylaxis. | 2016 | 4 |
| 11 | 2019 | 3 | |
| 12 | 2024 | 2 | |
| 13 | [Epilepsy surgery for focal cortical dysplasia and dysembryoplastic neuroepithelial tumor]. | 2000 | 2 |
| 14 | Successful bone marrow transplantation in a child with combined IgG subclass deficiency and neutropenia. | 1995 | 2 |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2017 | 1 | |
| 18 | 2017 | 1 |
About Ryuma Tanaka
Ryuma Tanaka is a scholar working on Molecular Biology, Genetics, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Immunology, having authored 18 papers that have together received 143 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Glioma Diagnosis and Treatment (3 papers), Neuroblastoma Research and Treatments (2 papers), CAR-T cell therapy research (2 papers), Immunotherapy and Immune Responses (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper). The work is most often cited by research in Genetics (25 citations), Oncology (47 citations), Immunology (32 citations), Genetics (29 citations) and Neurology (13 citations). Ryuma Tanaka has collaborated with scholars based in Japan, United States and South Africa. Frequent co-authors include Amy B. Heimberger, Xiaoyang Ling, Hillary G. Caruso, Verlene Henry, Aria Sabbagh, Jiyong Liang, Ibrahim Qaddoumi, Naoto Hara, S. Sherman and Takeshi Saito. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Molecular Case Studies, Microporous and Mesoporous Materials and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.